(Q31040425)

7 September 2017

CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma (English)

1 reference

head and neck squamous cell carcinoma

7 September 2017

0 references

0 references

1 reference

Zhien Feng

1

1 reference

7 September 2017

Wei Guo

2

1 reference

7 September 2017

Chenping Zhang

3

1 reference

7 September 2017

Qin Xu

4

1 reference

7 September 2017

Ping Zhang

5

1 reference

7 September 2017

Jian Sun

6

1 reference

7 September 2017

Hanguang Zhu

7

1 reference

7 September 2017

Zhonghe Wang

8

1 reference

7 September 2017

Jiang Li

9

1 reference

7 September 2017

Lizhen Wang

10

1 reference

7 September 2017

Bingshun Wang

11

1 reference

7 September 2017

Guoxin Ren

12

1 reference

7 September 2017

Tong Ji

13

1 reference

7 September 2017

Wenyong Tu

14

1 reference

7 September 2017

Xihu Yang

15

1 reference

7 September 2017

Weiliu Qiu

16

1 reference

7 September 2017

Li Mao

17

1 reference

7 September 2017

Zhiyuan Zhang

18

1 reference

7 September 2017

Wantao Chen

19

1 reference

7 September 2017

language of work or name

English

0 references

publication date

31 October 2011

1 reference

7 September 2017

1 reference

7 September 2017

6

1 reference

7 September 2017

10

1 reference

7 September 2017

e26399

1 reference

Creative Commons Attribution 4.0 International

7 September 2017

start time

31 October 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Neoadjuvant cisplatin chemotherapy before chemoradiation: a flawed paradigm?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Chemotherapy of squamous cell carcinoma of head and neck: the future is now.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Integrating molecular diagnostics into anticancer drug discovery.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Anal cancer: the end of the road for neoadjuvant chemoradiotherapy?

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Evidence-based recommendations against neoadjuvant chemotherapy for routine management of patients with squamous cell head and neck cancer

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Analysis of complete responders after initial treatment with chemotherapy in head and neck cancer

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3204964

Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases

25 November 2018

1 reference

12 December 2020

Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo

1 reference

12 December 2020

PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas

1 reference

12 December 2020

Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials

1 reference

12 December 2020

Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression

1 reference

12 December 2020

Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas

1 reference

12 December 2020

Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

1 reference

12 December 2020

Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial

1 reference

12 December 2020

First-Line Chemotherapy Improves the Resection Rate and Long-Term Survival of Locally Advanced (T4, any N, M0) Squamous Cell Carcinoma of the Thoracic Esophagus

1 reference

12 December 2020

Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma

1 reference

12 December 2020

Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0026399

Identifiers

DOI

1 reference

7 September 2017

0 references

1 reference

7 September 2017

PubMed publication ID

22065993

1 reference